Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Stifel

Stifel Maintains Buy Rating for Carnival: Here's What You Need To Know

Stifel has decided to maintain its Buy rating of Carnival (NYSE:CCL) and lower its price target from $30.00 to $20.00. Shares of Carnival are trading down 2.69% over the last 24 hours, at $10.56 per share. A move to $20.00 would account for a 89.44% increase from the current share…

Benzinga

Why Carnival Shares Are Falling Today

Carnival Corp (NYSE: CCL) shares are trading lower by 3.92% to $10.42. Wells Fargo maintained an Underweight rating on the stock and lowered its price target from $21 to $13. Stifel lowered its price target on the stock from $30 to $20.

Benzinga

Read How Analysts Reacted To Darden Restaurants' Q4 Results

Wedbush analyst Nick Setyan lowered the price target on Darden Restaurants Inc (NYSE:DRI) to $122 (3% upside) from $140 and kept a Neutral rating on the shares. The analyst noted that FY23 guidance is predicated on normalization in inflation trends in the second half and has lowered his FY23 EPS estimate to $7.60 from $8.41…

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Xenon Pharmaceuticals Shares Drop On Proposed Public Offering

Xenon Pharmaceuticals Inc (NASDAQ:XENE) announced an underwritten public offering of its common shares. Underwriters of the offering will be granted an option for a period of 30 days to purchase an additional 15% of common shares at the public offering price. Jefferies, J.P. Morgan, SVB Securities, and Stifel are acting as joint…

Benzinga

What's Going On With Netflix Stock?

Shares of several companies are trading higher Tuesday as stocks rebound following weakness stemming from recent Fed policy tightening. However, Netflix Inc (NASDAQ: NFLX) is underperforming. So what's going on?

Benzinga

Stifel Maintains Hold Rating for Netflix: Here's What You Need To Know

Stifel has decided to maintain its Hold rating of Netflix (NASDAQ:NFLX) and lower its price target from $300.00 to $240.00. Shares of Netflix are trading down 1.99% over the last 24 hours, at $172.01 per share. A move to $240.00 would account for a 39.53% increase from the current share…

Benzinga

Read How Analysts Reacted To Devon Energy's RimRock Transaction

Mizuho Securities analyst Vincent Lovaglio raised the price target for Devon Energy Corp (NYSE:DVN) to $94 (an upside of 28%) from $92, reflecting the $865 million Rim Rock acquisition. The analyst states that the transaction adds 15kboed and 38k net acres to the company's existing 48kboed and 85k net acre Bakken position at ~4x free cash…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Stifel Maintains Hold Rating for Campbell Soup: Here's What You Need To Know

Stifel has decided to maintain its Hold rating of Campbell Soup (NYSE:CPB) and raise its price target from $46.00 to $48.00. Shares of Campbell Soup are trading up 0.83% over the last 24 hours, at $47.70 per share. A move to $48.00 would account for a 0.62% increase from the…

Benzinga

Here's Why Stifel Slashed Price Target On Nike

Stifel analyst Jim Duffy lowered the price target on Nike Inc (NYSE:NKE) to $150 from $160, implying a 23.99% upside. Duffy kept a Buy rating on the shares. The analyst slashed the price target, considering the business restrictions in China due to the rise in COVID-19 cases and the strengthened U.S. dollar position. He said…

Benzinga

Read How Analysts Reacted To MongoDB Post Q1 Earnings Beat

Analysts appreciated MongoDB, Inc's (NASDAQ:MDB) Q1 beat but cut the price target to reflect macro headwinds. Needham analyst Mike Cikos maintained MongoDB with a Buy rating and lowered the price target from $362 to $310. The price target change reflected the declines in the broader stock market. Cikos acknowledged MongoDB's strong 1QF23 feat outperforming guidance and expectations.…

Benzinga

Camber Energy vs. Centennial Resource Development: Which Oil & Gas Stock is a Better Buy?

In this article I will analyze and compare Camber Energy (CEI) and Centennial Resource Development (CDEV) to determine which oil & gas stock is currently a better investment.

StockNews.com

2 Cannabis Stocks to Avoid After Stifel Cuts Their Price Targets

Surging inflation and the Fed’s hawkish monetary policy stance could keep the stock market under pressure in the near term. Amid the uncertainties surrounding the economy and the stock market, Stifel analysts are maintaining a negative outlook on the cannabis industry and have cut their price targets for the stocks…

StockNews.com

Benzinga's Top Ratings Upgrades, Downgrades For May 12, 2022

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2022

Upgrades

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Stifel Maintains Hold Rating for Inogen: Here's What You Need To Know

Stifel has decided to maintain its Hold rating of Inogen (NASDAQ:INGN) and lower its price target from $40.00 to $30.00. Shares of Inogen are trading down 4.15% over the last 24 hours, at $23.91 per share. A move to $30.00 would account for a 25.5% increase from the current share…

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 6, 2022

Upgrades For Coupang Inc (NYSE:CPNG), JP Morgan upgraded the previous rating of Neutral to Overweight. The stock has a 52-week-high of $46.00 and a 52-week-low of $11.91. At the end of the last trading period, Coupang closed at $11.99.

Benzinga

Stifel: Weedmaps Best Positioned To Capitalize On Category Growth

In a recent first-quarter outlook report, analysts from Stifel, an American multinational independent investment bank and financial services company, had positive comments on Weedmaps, a tech company serving the cannabis industry,

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2022

Upgrades

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 29, 2022

Upgrades

Benzinga

Stifel Maintains Buy Rating for Microsoft: Here's What You Need To Know

Stifel has decided to maintain its Buy rating of Microsoft (NASDAQ:MSFT) and lower its price target from $380.00 to $350.00. Shares of Microsoft are trading up 5.64% over the last 24 hours, at $285.45 per share. A move to $350.00 would account for a 22.61% increase from the current share…

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 26, 2022

Upgrades According to Susquehanna, the prior rating for Boyd Gaming Corp (NYSE:BYD) was changed from Neutral to Positive. At the moment, the stock has a 52-week-high of $72.72 and a 52-week-low of $50.38. Boyd Gaming closed at $64.20 at the end of the last trading period.

Benzinga

10 Biggest Price Target Changes For Tuesday

HC Wainwright & Co. raised Nkarta, Inc. (NASDAQ: NKTX) price target from $25 to $36. Nkarta shares fell 7.2% to $17.38 in pre-market trading.

Benzinga

RBC Capital Cuts Shopify's Price Target By 23%

Shopify Inc (NYSE:SHOP) (TSX:SHOP) price target has been lowered to $1000 (an upside of 116%) from $1300 by RBC Capital analyst Paul Treiber. The analyst maintained the Outperform rating on the shares. The analyst states that the proposed changes to Shopify’s share structure may be contentious. Treiber adds that while some terms in the proposal…

Benzinga

Stifel Downgrades Rating to Hold for Reynolds Consumer, Lowers Price Target To $31

Stifel downgraded its rating of Reynolds Consumer (NASDAQ:REYN) to Hold with a price target of $31.00, changing its price target from $33.00 to $31.00. Shares of Reynolds Consumer are trading down 3.6% over the last 24 hours, at $28.38 per share.

Benzinga

Read Why Stifel Downgraded Reynolds Consumer Products

Stifel analyst Mark Astrachan downgraded Reynolds Consumer Products Inc (NASDAQ:REYN) to Hold from Buy with a reduced price target of $31, down from $33, implying an 8.7% upside. The analyst has reduced 2022 and 2023 EPS estimates below consensus, reflecting gross margin pressure from higher input costs. Astrachan expects volumes to worsen as the company…

1 … 8 9 10 11

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.